Mao et al. reported that SAPCD2 expression level peaked in the early G1 phase, dramatically decreased in late G1, S, and G2 phases, and increased again during the M and G2 phases in gastric, breast, and lung cancer cell lines 15. The gene discussed is SAPCD2; the disease is lung carcinoma.